Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Therapeutics

49.53
-0.0200-0.04%
Post-market: 49.530.00000.00%16:41 EDT
Volume:593.75K
Turnover:29.44M
Market Cap:3.91B
PE:-10.48
High:50.07
Open:49.11
Low:48.09
Close:49.55
Loading ...

PTC Therapeutics price target raised to $70 from $52 at Baird

TIPRANKS
·
03 Dec 2024

PTC Therapeutics price target raised to $41 from $31 at BofA

TIPRANKS
·
03 Dec 2024

RBC Upgrades PTC Therapeutics to Outperform From Sector Perform, Raises Price Target to $63 From $39

MT Newswires Live
·
03 Dec 2024

Cautious Outlook on PTC Therapeutics Amid Regulatory Uncertainties and Clinical Data Gaps

TIPRANKS
·
03 Dec 2024

PTC Therapeutics price target raised to $56 from $45 at Barclays

TIPRANKS
·
03 Dec 2024

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), PTC Therapeutics (PTCT) and Vir Biotechnology (VIR)

TIPRANKS
·
03 Dec 2024

Barclays Keeps Their Hold Rating on PTC Therapeutics (PTCT)

TIPRANKS
·
03 Dec 2024

U.S. RESEARCH ROUNDUP-Citigroup, Salesforce, Zscaler

Reuters
·
03 Dec 2024

PTC Therapeutics Inc : Jefferies Raises Target Price to $62 From $55

THOMSON REUTERS
·
03 Dec 2024

Sector Update: Health Care Stocks Slipping Late Afternoon

MT Newswires Live
·
03 Dec 2024

Sector Update: Health Care Stocks Softer Monday Afternoon

MT Newswires Live
·
03 Dec 2024

PTC Therapeutics Inks Licensing Pact With Novartis Worth Up To ~$3 Billion For Huntington's Program

Benzinga
·
03 Dec 2024

PTC Therapeutics Strikes Up to $2.9 Billion Licensing Deal With Novartis for Huntington's Disease Drug Candidate

MT Newswires
·
02 Dec 2024

PTC Therapeutics Shares up 15.4% After Co Signs up to $2.9 Billion Licensing Deal With Novartis

THOMSON REUTERS
·
02 Dec 2024

Sector Update: Health Care Stocks Mixed Pre-Bell Monday

MT Newswires Live
·
02 Dec 2024

BUZZ-PTC Therapeutics rises on signing up to $2.9 billion licensing deal with Novartis

Reuters
·
02 Dec 2024

PTC Therapeutics Signs Exclusive Global License Deal With Novartis Unit for PTC518 Huntington's Disease Program; Shares Rise Premarket

MT Newswires Live
·
02 Dec 2024

PTC Therapeutics signs up to $1.9 billion licensing deal with Novartis

Reuters
·
02 Dec 2024

BRIEF-PTC Therapeutics Enters Into A Global License And Collaboration Agreement With Novartis For PTC518 Huntington's Disease Program

Reuters
·
02 Dec 2024

PTC Therapeutics Shares Jump 14.1% Premarket After Agreement With Novartis for Huntington's Disease Program

THOMSON REUTERS
·
02 Dec 2024